Triclofos sodium

This classification denotes a sedative and hypnotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9F90KA5Q8U. European Medicines Agency schedules Triclofos sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15606MIG. Triclofos sodium generally arises in the molecular formula C2H3CL3O4P.NA. The term 'triclofos sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule triclofos sodium under HS 29199090 and SITC 51631. As of Q4 2014, TRICLOFOS SODIUM remains US FDA's Preferred Term for this commodity. Triclofos sodium bears US NLM identifiers UMLS ID C0355022 and NCI Concept Code C66630. SMILES: C(C(CL)(CL)CL)OP(=O)(O)[O-].[NA+].